Loading…
Serogroup B meningococcal vaccination practice patterns on college campuses
Most Neisseria meningitidis involved in invasive disease among American college students express serogroup B antigen. The Advisory Committee on Immunization Practices (ACIP) recommends healthcare providers (HCPs) share clinical decision making with patients to determine individual value of meningoco...
Saved in:
Published in: | Vaccine 2020-10, Vol.38 (46), p.7350-7356 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c393t-44cb0ebe5a505f2cae3b4b9cc3dfef760e3175a95f035a23b3f38b4be09b0063 |
---|---|
cites | cdi_FETCH-LOGICAL-c393t-44cb0ebe5a505f2cae3b4b9cc3dfef760e3175a95f035a23b3f38b4be09b0063 |
container_end_page | 7356 |
container_issue | 46 |
container_start_page | 7350 |
container_title | Vaccine |
container_volume | 38 |
creator | Haimowitz, Rachel Torres, Rachel Caleb, Susan Thompson, Danielle Smith, Allison Ciotoli, Carlo Dannenbaum, Martha Fu, Linda Y. |
description | Most Neisseria meningitidis involved in invasive disease among American college students express serogroup B antigen. The Advisory Committee on Immunization Practices (ACIP) recommends healthcare providers (HCPs) share clinical decision making with patients to determine individual value of meningococcal serogroup B vaccination (MenB) rather than routinely recommend vaccination as with the meningococcal A,C,W,Y vaccine (MenACWY). This study examines the attitudes and practices of HCPs working in college student health centers (SHCs) regarding the recommendation and administration of MenB to students.
The study was conducted as an online and phone survey of SHC HCPs from a sample of colleges across the United States between May 2017 and July 2018. Items compared college SHC policies and practices for MenB to those for MenACWY. It also assessed perceived barriers to and facilitators of MenB delivery to students.
Among the 147 respondents, almost 50% more reported their SHC stocked and administered MenACWY (54.1%) than MenB (37%) (p = .004). Almost five times as many colleges required their students receive MenACWY as MenB (53.5% vs. 10.5%, p |
doi_str_mv | 10.1016/j.vaccine.2020.09.035 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2448636560</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X20311956</els_id><sourcerecordid>2448636560</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-44cb0ebe5a505f2cae3b4b9cc3dfef760e3175a95f035a23b3f38b4be09b0063</originalsourceid><addsrcrecordid>eNqFkE1LxDAQhoMouq7-BKXgxUvrpGna7UlU_ELBgx68hXR2umRpm5q0C_57I109ePE0EJ55583D2AmHhAPPL9bJRiOajpIUUkigTEDIHTbji0LEqeSLXTaDNM_ijMP7ATv0fg0AUvBynx0IARzKopixp1dyduXs2EfXUUud6VYWLaJuoilfD8Z2Ue80DgYp6vUwkOt8FB7RNg2tKELd9qMnf8T2at14Ot7OOXu7u327eYifX-4fb66eYxSlGOIswwqoIqklyDpFTaLKqhJRLGuqixxI8ELqUtbhRzoVlajFIhAEZQWQizk7n2J7Zz9G8oNqjUdqGt2RHb1Ks2yRi1zmENCzP-jajq4L5QIloQgFRBEoOVHorPeOatU702r3qTiob9lqrbay1bdsBaUK1cLe6TZ9rFpa_m792A3A5QRQsLEx5JRHQx3S0jjCQS2t-efEF-Fvkzw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2450750537</pqid></control><display><type>article</type><title>Serogroup B meningococcal vaccination practice patterns on college campuses</title><source>ScienceDirect Journals</source><creator>Haimowitz, Rachel ; Torres, Rachel ; Caleb, Susan ; Thompson, Danielle ; Smith, Allison ; Ciotoli, Carlo ; Dannenbaum, Martha ; Fu, Linda Y.</creator><creatorcontrib>Haimowitz, Rachel ; Torres, Rachel ; Caleb, Susan ; Thompson, Danielle ; Smith, Allison ; Ciotoli, Carlo ; Dannenbaum, Martha ; Fu, Linda Y.</creatorcontrib><description>Most Neisseria meningitidis involved in invasive disease among American college students express serogroup B antigen. The Advisory Committee on Immunization Practices (ACIP) recommends healthcare providers (HCPs) share clinical decision making with patients to determine individual value of meningococcal serogroup B vaccination (MenB) rather than routinely recommend vaccination as with the meningococcal A,C,W,Y vaccine (MenACWY). This study examines the attitudes and practices of HCPs working in college student health centers (SHCs) regarding the recommendation and administration of MenB to students.
The study was conducted as an online and phone survey of SHC HCPs from a sample of colleges across the United States between May 2017 and July 2018. Items compared college SHC policies and practices for MenB to those for MenACWY. It also assessed perceived barriers to and facilitators of MenB delivery to students.
Among the 147 respondents, almost 50% more reported their SHC stocked and administered MenACWY (54.1%) than MenB (37%) (p = .004). Almost five times as many colleges required their students receive MenACWY as MenB (53.5% vs. 10.5%, p < .001). A greater percentage requested students to submit records for MenACWY than MenB (77.3% vs. 46.9%, p < .001), and over three times as many tracked student-body coverage rates for MenACWY than MenB (55.6% vs. 15.8%, p < .001). Nearly three quarters of respondents estimated their college’s student body MenB coverage rate to be ≤ 10% or were unable to provide any estimate. Factors perceived by over half of the participants as moderate to extreme barriers to administering MenB included high upfront costs for SHCs to purchase and stock MenB (68.7%), and high out-of-pocket costs for students to receive it (82.8%).
A minority of college SHCs require, offer or track Men B vaccination on their campuses. Financial concerns are common barriers to SHCs’ stocking and administering MenB to students.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2020.09.035</identifier><identifier>PMID: 33010977</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Antigens ; Clinical decision making ; Clinical practice guidelines ; College ; College campuses ; College students ; Colleges & universities ; Decision making ; Education ; Health care facilities ; Humans ; Immunization ; Male ; Meningococcal Infections - epidemiology ; Meningococcal Infections - prevention & control ; Meningococcal Vaccines ; Neisseria meningitidis, Serogroup B ; Practice guidelines ; Quality control ; Quality improvement ; Serogroup ; Students ; United States ; Vaccination ; Vaccines ; Young adult</subject><ispartof>Vaccine, 2020-10, Vol.38 (46), p.7350-7356</ispartof><rights>2020 Elsevier Ltd</rights><rights>Copyright © 2020 Elsevier Ltd. All rights reserved.</rights><rights>2020. Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-44cb0ebe5a505f2cae3b4b9cc3dfef760e3175a95f035a23b3f38b4be09b0063</citedby><cites>FETCH-LOGICAL-c393t-44cb0ebe5a505f2cae3b4b9cc3dfef760e3175a95f035a23b3f38b4be09b0063</cites><orcidid>0000-0002-5649-5167 ; 0000-0002-8378-8993</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33010977$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Haimowitz, Rachel</creatorcontrib><creatorcontrib>Torres, Rachel</creatorcontrib><creatorcontrib>Caleb, Susan</creatorcontrib><creatorcontrib>Thompson, Danielle</creatorcontrib><creatorcontrib>Smith, Allison</creatorcontrib><creatorcontrib>Ciotoli, Carlo</creatorcontrib><creatorcontrib>Dannenbaum, Martha</creatorcontrib><creatorcontrib>Fu, Linda Y.</creatorcontrib><title>Serogroup B meningococcal vaccination practice patterns on college campuses</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Most Neisseria meningitidis involved in invasive disease among American college students express serogroup B antigen. The Advisory Committee on Immunization Practices (ACIP) recommends healthcare providers (HCPs) share clinical decision making with patients to determine individual value of meningococcal serogroup B vaccination (MenB) rather than routinely recommend vaccination as with the meningococcal A,C,W,Y vaccine (MenACWY). This study examines the attitudes and practices of HCPs working in college student health centers (SHCs) regarding the recommendation and administration of MenB to students.
The study was conducted as an online and phone survey of SHC HCPs from a sample of colleges across the United States between May 2017 and July 2018. Items compared college SHC policies and practices for MenB to those for MenACWY. It also assessed perceived barriers to and facilitators of MenB delivery to students.
Among the 147 respondents, almost 50% more reported their SHC stocked and administered MenACWY (54.1%) than MenB (37%) (p = .004). Almost five times as many colleges required their students receive MenACWY as MenB (53.5% vs. 10.5%, p < .001). A greater percentage requested students to submit records for MenACWY than MenB (77.3% vs. 46.9%, p < .001), and over three times as many tracked student-body coverage rates for MenACWY than MenB (55.6% vs. 15.8%, p < .001). Nearly three quarters of respondents estimated their college’s student body MenB coverage rate to be ≤ 10% or were unable to provide any estimate. Factors perceived by over half of the participants as moderate to extreme barriers to administering MenB included high upfront costs for SHCs to purchase and stock MenB (68.7%), and high out-of-pocket costs for students to receive it (82.8%).
A minority of college SHCs require, offer or track Men B vaccination on their campuses. Financial concerns are common barriers to SHCs’ stocking and administering MenB to students.</description><subject>Antigens</subject><subject>Clinical decision making</subject><subject>Clinical practice guidelines</subject><subject>College</subject><subject>College campuses</subject><subject>College students</subject><subject>Colleges & universities</subject><subject>Decision making</subject><subject>Education</subject><subject>Health care facilities</subject><subject>Humans</subject><subject>Immunization</subject><subject>Male</subject><subject>Meningococcal Infections - epidemiology</subject><subject>Meningococcal Infections - prevention & control</subject><subject>Meningococcal Vaccines</subject><subject>Neisseria meningitidis, Serogroup B</subject><subject>Practice guidelines</subject><subject>Quality control</subject><subject>Quality improvement</subject><subject>Serogroup</subject><subject>Students</subject><subject>United States</subject><subject>Vaccination</subject><subject>Vaccines</subject><subject>Young adult</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFkE1LxDAQhoMouq7-BKXgxUvrpGna7UlU_ELBgx68hXR2umRpm5q0C_57I109ePE0EJ55583D2AmHhAPPL9bJRiOajpIUUkigTEDIHTbji0LEqeSLXTaDNM_ijMP7ATv0fg0AUvBynx0IARzKopixp1dyduXs2EfXUUud6VYWLaJuoilfD8Z2Ue80DgYp6vUwkOt8FB7RNg2tKELd9qMnf8T2at14Ot7OOXu7u327eYifX-4fb66eYxSlGOIswwqoIqklyDpFTaLKqhJRLGuqixxI8ELqUtbhRzoVlajFIhAEZQWQizk7n2J7Zz9G8oNqjUdqGt2RHb1Ks2yRi1zmENCzP-jajq4L5QIloQgFRBEoOVHorPeOatU702r3qTiob9lqrbay1bdsBaUK1cLe6TZ9rFpa_m792A3A5QRQsLEx5JRHQx3S0jjCQS2t-efEF-Fvkzw</recordid><startdate>20201027</startdate><enddate>20201027</enddate><creator>Haimowitz, Rachel</creator><creator>Torres, Rachel</creator><creator>Caleb, Susan</creator><creator>Thompson, Danielle</creator><creator>Smith, Allison</creator><creator>Ciotoli, Carlo</creator><creator>Dannenbaum, Martha</creator><creator>Fu, Linda Y.</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5649-5167</orcidid><orcidid>https://orcid.org/0000-0002-8378-8993</orcidid></search><sort><creationdate>20201027</creationdate><title>Serogroup B meningococcal vaccination practice patterns on college campuses</title><author>Haimowitz, Rachel ; Torres, Rachel ; Caleb, Susan ; Thompson, Danielle ; Smith, Allison ; Ciotoli, Carlo ; Dannenbaum, Martha ; Fu, Linda Y.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-44cb0ebe5a505f2cae3b4b9cc3dfef760e3175a95f035a23b3f38b4be09b0063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antigens</topic><topic>Clinical decision making</topic><topic>Clinical practice guidelines</topic><topic>College</topic><topic>College campuses</topic><topic>College students</topic><topic>Colleges & universities</topic><topic>Decision making</topic><topic>Education</topic><topic>Health care facilities</topic><topic>Humans</topic><topic>Immunization</topic><topic>Male</topic><topic>Meningococcal Infections - epidemiology</topic><topic>Meningococcal Infections - prevention & control</topic><topic>Meningococcal Vaccines</topic><topic>Neisseria meningitidis, Serogroup B</topic><topic>Practice guidelines</topic><topic>Quality control</topic><topic>Quality improvement</topic><topic>Serogroup</topic><topic>Students</topic><topic>United States</topic><topic>Vaccination</topic><topic>Vaccines</topic><topic>Young adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Haimowitz, Rachel</creatorcontrib><creatorcontrib>Torres, Rachel</creatorcontrib><creatorcontrib>Caleb, Susan</creatorcontrib><creatorcontrib>Thompson, Danielle</creatorcontrib><creatorcontrib>Smith, Allison</creatorcontrib><creatorcontrib>Ciotoli, Carlo</creatorcontrib><creatorcontrib>Dannenbaum, Martha</creatorcontrib><creatorcontrib>Fu, Linda Y.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Database (Proquest)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database (Proquest)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Haimowitz, Rachel</au><au>Torres, Rachel</au><au>Caleb, Susan</au><au>Thompson, Danielle</au><au>Smith, Allison</au><au>Ciotoli, Carlo</au><au>Dannenbaum, Martha</au><au>Fu, Linda Y.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serogroup B meningococcal vaccination practice patterns on college campuses</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2020-10-27</date><risdate>2020</risdate><volume>38</volume><issue>46</issue><spage>7350</spage><epage>7356</epage><pages>7350-7356</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>Most Neisseria meningitidis involved in invasive disease among American college students express serogroup B antigen. The Advisory Committee on Immunization Practices (ACIP) recommends healthcare providers (HCPs) share clinical decision making with patients to determine individual value of meningococcal serogroup B vaccination (MenB) rather than routinely recommend vaccination as with the meningococcal A,C,W,Y vaccine (MenACWY). This study examines the attitudes and practices of HCPs working in college student health centers (SHCs) regarding the recommendation and administration of MenB to students.
The study was conducted as an online and phone survey of SHC HCPs from a sample of colleges across the United States between May 2017 and July 2018. Items compared college SHC policies and practices for MenB to those for MenACWY. It also assessed perceived barriers to and facilitators of MenB delivery to students.
Among the 147 respondents, almost 50% more reported their SHC stocked and administered MenACWY (54.1%) than MenB (37%) (p = .004). Almost five times as many colleges required their students receive MenACWY as MenB (53.5% vs. 10.5%, p < .001). A greater percentage requested students to submit records for MenACWY than MenB (77.3% vs. 46.9%, p < .001), and over three times as many tracked student-body coverage rates for MenACWY than MenB (55.6% vs. 15.8%, p < .001). Nearly three quarters of respondents estimated their college’s student body MenB coverage rate to be ≤ 10% or were unable to provide any estimate. Factors perceived by over half of the participants as moderate to extreme barriers to administering MenB included high upfront costs for SHCs to purchase and stock MenB (68.7%), and high out-of-pocket costs for students to receive it (82.8%).
A minority of college SHCs require, offer or track Men B vaccination on their campuses. Financial concerns are common barriers to SHCs’ stocking and administering MenB to students.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>33010977</pmid><doi>10.1016/j.vaccine.2020.09.035</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-5649-5167</orcidid><orcidid>https://orcid.org/0000-0002-8378-8993</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0264-410X |
ispartof | Vaccine, 2020-10, Vol.38 (46), p.7350-7356 |
issn | 0264-410X 1873-2518 |
language | eng |
recordid | cdi_proquest_miscellaneous_2448636560 |
source | ScienceDirect Journals |
subjects | Antigens Clinical decision making Clinical practice guidelines College College campuses College students Colleges & universities Decision making Education Health care facilities Humans Immunization Male Meningococcal Infections - epidemiology Meningococcal Infections - prevention & control Meningococcal Vaccines Neisseria meningitidis, Serogroup B Practice guidelines Quality control Quality improvement Serogroup Students United States Vaccination Vaccines Young adult |
title | Serogroup B meningococcal vaccination practice patterns on college campuses |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T21%3A04%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serogroup%20B%20meningococcal%20vaccination%20practice%20patterns%20on%20college%20campuses&rft.jtitle=Vaccine&rft.au=Haimowitz,%20Rachel&rft.date=2020-10-27&rft.volume=38&rft.issue=46&rft.spage=7350&rft.epage=7356&rft.pages=7350-7356&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2020.09.035&rft_dat=%3Cproquest_cross%3E2448636560%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c393t-44cb0ebe5a505f2cae3b4b9cc3dfef760e3175a95f035a23b3f38b4be09b0063%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2450750537&rft_id=info:pmid/33010977&rfr_iscdi=true |